Pharmaceuticals account for the majority of India exports to Ukraine. India is 3rd largest exporter of pharma products to the country in value terms. On the other hand, Ukraine is one of the biggest exporters of sunflower oil to India.
The worsening Ukraine-Russia situation has the world worried, as it has wider security and economic implications for several countries, including India, with growth yet to come back on track following the COVID-19 outbreak.
Indian equities crashed more than 2% at the opening bell on Feb. 22 after Russia recognised two rebel-dominated regions of Ukraine, escalating the simmering crisis that has scorched markets across the world for the past several days.
India's bilateral trade turnover stood at $2.52 billion in 2019-20, up over 25% from 2.01 billion in 2015-16. However, the turnover in 2019-20 declined by 7.59% from 2.73 billion in 2018-19.
India exports have surged a whopping 79% from $259.11 million in 2015-16 to $463.81 million in 2019-20. On the other hand, imports have increased by over 17% from $1751.1 million to $2060.79 million during the given period. Pharma account for the majority of Indian exports to Ukraine. India is the 3rd largest exporter of pharmaceutical products to Ukraine, after Germany and France, in value terms.
A number of Indian companies like Rambaxy, Dr. Reddy Lab. & Sun Group has their representative offices in Ukraine. Representatives of major pharmaceutical companies have set up an India Pharmaceutical Manufacturer Association (IPMA) in Ukraine. The biggest macro headwind for India is a rally in crude prices. The inflationary consequence of this will force the RBI to abandon its dovish monetary stance. Crude oil has surged about 3.5% to $97 per barrel, while gold has crossed the $1900 mark amid risk aversion.
The India-Ukraine bilateral trade assumes significance amid the escalating border tensions between the Eastern European nation and Russia. With the regions peace hanging in balance, Indian companies with exposure to the European union have come under pressure as investors fear the impact on business from the escalating tension.